4 investment stories you missed in the ASX200 this week

Here are 4 investment stories you may have missed from the ASX200 (ASX:XJO) this week.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here are four big stories you may have missed that affected the S&P/ASX 200 (Index: ^AXJO) (ASX:XJO) this week:

Out-of-cycle interest hikes continue

The National Australia Bank Ltd (ASX: NAB) rate halt was short-lived with the big four bank saying it could no longer withhold increasing interest rates again because of funding pressures.

NAB decided to increase the interest rate by 0.16% per annum for most types of borrowers.

This should be a boost to the bottom line, but it won't help homeowners or investors to afford their huge pile of debt.

Disappointing healthcare result

Sleepy apnea business ResMed Inc. (ASX: RMD) unveiled its second quarter result to investors this week, which sadly disappointed investors sending the share price down by 12% on Friday.

The healthcare business missed analyst expectations by 3%, management will be hoping that non-America sales can start growing at a good pace soon.

Challenger Ltd (ASX: CGF) facing challenges

The retirement income business disappointed shareholders this week when it said profit this half-year and for the full-year would be less than previously expected.

Falling asset prices have hurt the asset manager's balance sheet and fee earnings.

However, despite the negativity I plan to hold my Challenger shares for many years to come.

Coles Group Limited (ASX: COL) announces automated warehouse price

We've known about the automated warehouses that Coles plans to build for a while, but this week the supermarket giant said how much it will actually cost.

The two WITRON automated warehouses, one in Queensland and one in New South Wales, will cost a total of $950 million over six years.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited. The Motley Fool Australia owns shares of and has recommended Challenger Limited. The Motley Fool Australia owns shares of COLESGROUP DEF SET. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Mini house on a laptop.
Dividend Investing

Do ASX 200 dividend shares out-earn Aussie property?

We compare the forecast FY25 dividend yields of the top 10 ASX 200 companies to rental property yields.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Best Shares

Top ASX shares to buy with $500 in November 2024

$500 worth of ASX shares might not sound like a huge investment. But, to realise the benefits of compounding, you…

Read more »

A diverse group of people form a circle at a park and raise their arms together.
Share Market News

Here are the top 10 ASX 200 shares today

ASX investors ended the trading week on a high note this Friday...

Read more »

Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Catapult, De Grey Mining, Domino's, and Nufarm shares are charging higher

These shares are ending the week strongly. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Three analysts look at tech options on a wall screen
Technology Shares

Up 70%, is it too late to invest in Xero shares?

This ASX tech darling hit a new all-time share price record yesterday.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Healius, Opthea, Peninsula Energy, and Wildcat shares are falling today

These shares are having a tough finish to the week. But why?

Read more »